Diversified Financial Services
Company Overview of Alkermes Clinical Partners LP
Alkermes Clinical Partners, L.P. was terminated in December 2003. Previously, Alkermes Clinical Partners was engaged in funding of the further development and clinical testing of a family of molecules, receptor-mediated permeabilizers, designated by Alkermes, Inc. for human pharmaceutical use in the United States and Canada. The company was formed under the laws of the State of Delaware in February 1992.
64 Sidney St
Cambridge, MA 02139
Founded in 1992
Key Executives for Alkermes Clinical Partners LP
Alkermes Clinical Partners LP does not have any Key Executives recorded.
Similar Private Companies By Industry
|1199 S.E.I.U. Federal Credit Union||United States|
|121 Financial Credit Union||United States|
|123 LumpSum Holdings, LLC||United States|
|12five Capital, LLC||United States|
|167th TFR Federal Credit Union||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Alkermes Clinical Partners LP, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.